Year: 2013
Type: article
Abstract: Multi Drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are emerging as a major challenges across globe including in India as narrated by the World Health Organization (WHO) for success the Stop TB strategy, launched in 2006.[1] MDR-TB is defined as tuberculosis disease where the bacilli is resistant to isoniazid (H) and rifampicin (R), with or without resistance to other drugs. Irregular consumption and frequent interruption in taking treatment for TB is the most common cause of acquiring multidrug resistance.
Authors: Deepak Saxena, Pankaj Bhardawaj
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2142170793
